In contrast, the TET2, FLT3, RUNX1, BCOR and spliceosome mutations were more common in the IDO1-high group, which were commonly enriched in myelodysplastic syndrome (MDS)-transformed AML (Table S3). This evidence concerns the gene RUNX1 and myelodysplastic syndrome.